v3.26.3
Condensed Statements of Stockholders’ Equity (Unaudited) - USD ($)
Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2023 $ 1,237 $ 707 $ 27,825,061 $ (36,259,736) $ (8,432,731)
Balance (in Shares) at Dec. 31, 2023 12,364,815 7,072,300      
Retroactive application of recapitalization $ (217) $ (123) 340
Retroactive application of recapitalization (in Shares) (2,159,935) (1,235,418)      
Issuance of warrants     5,712,588 5,712,588
Net loss       (65,088,786) (65,088,786)
Balance at Dec. 31, 2024 $ 1,020 $ 584 33,537,989 (101,348,522) (67,808,929)
Balance (in Shares) at Dec. 31, 2024 10,204,880 5,836,882      
Net loss   (35,453,632) (35,453,632)
Reverse recapitalization, net of expenses $ (1,020) $ 3,916 173,821,543 173,824,439
Reverse recapitalization, net of expenses (in Shares) (10,204,880) 39,163,783      
Share based compensation expense   $ 15 6,895,480 6,895,495
Share based compensation expense (in Shares)   142,785      
Exercise of Series B warrants   $ 50 (50)
Exercise of Series B warrants (in Shares)   500,000      
Issuance of March 2025 closing shares and warrants   $ 75 9,569,109 9,569,184
Issuance of March 2025 closing shares and warrants (in Shares)   750,000      
Change in fair value of Series C Warrants   498,771 498,771
Issuance of interest shares   $ 10 646,657 646,667
Issuance of interest shares (in Shares)   102,893      
Issuance of placement shares   $ 8 353,242 353,250
Issuance of placement shares (in Shares)   75,000      
Balance at Jun. 30, 2025 $ 4,658 225,322,741 (136,802,154) 88,525,245
Balance (in Shares) at Jun. 30, 2025 46,571,343      
Balance at Dec. 31, 2024 $ 1,020 $ 584 33,537,989 (101,348,522) (67,808,929)
Balance (in Shares) at Dec. 31, 2024 10,204,880 5,836,882      
Net loss       (69,590,462) (69,590,462)
Reverse recapitalization, net of expenses $ (1,020) $ 3,916 173,821,544 173,824,440
Reverse recapitalization, net of expenses (in Shares) (10,204,880) 39,163,783      
Share based compensation expense   $ 31 9,969,081 9,969,112
Share based compensation expense (in Shares)   306,695      
Exercise of Series B warrants   $ 50 (50)
Exercise of Series B warrants (in Shares)   500,000      
Issuance of March 2025 closing shares and warrants   $ 75 9,569,109 9,569,184
Issuance of March 2025 closing shares and warrants (in Shares)   750,000      
Change in fair value of Series C Warrants   498,771 498,771
Issuance of interest shares   $ 43 1,859,968 1,860,011
Issuance of interest shares (in Shares)   427,979      
Issuance of placement shares   $ 8 353,242 353,250
Issuance of placement shares (in Shares)   75,000      
Issuance of common stock   $ 142 4,315,128 4,315,270
Issuance of common stock (in Shares)   1,417,544      
Balance at Dec. 31, 2025 $ 4,849 233,924,782 (170,938,984) 62,990,647
Balance (in Shares) at Dec. 31, 2025 48,477,883      
Net loss   (38,819,463) (38,819,463)
Share based compensation expense   $ 158 3,353,301 3,353,459
Share based compensation expense (in Shares)   1,580,161      
Common stock withheld for employee tax obligations   (949,300) (949,300)
Common stock withheld for employee tax obligations (in Shares)   (385,601)      
Issuance of interest shares   $ 25 613,309 613,334
Issuance of interest shares (in Shares)   247,785      
Issuance of Employee Stock Purchase Plan shares   $ 6 85,647 85,653
Issuance of Employee Stock Purchase Plan shares (in Shares)   57,485      
Issuance of common stock   $ 440 3,008,581 3,009,021
Issuance of common stock (in Shares)   4,402,410      
Issuance of commitment shares   $ 52 785,148 785,200
Issuance of commitment shares (in Shares)   520,000      
Issuance of common stock for intellectual property acquisition   $ 12 182,367 182,379
Issuance of common stock for intellectual property acquisition (in Shares)   121,578      
Balance at Jun. 30, 2026 $ 5,542 $ 241,003,835 $ (209,758,447) $ 31,250,930
Balance (in Shares) at Jun. 30, 2026 55,021,701